Now we have conflict on hypertension drugs
We now are faced with conflicts of opinion between NICE and the BHS on the management of hypertension (News, March 15).
NICE it appears, advocates the 'somnification' of our patients with either thiazide diruetics or ß-blockers as first-line therapy.
BHS on the other hand has taken a rather more holistic view in advocating the ABCD rule and to manage additional risk factors.
With such conflicts, NICE, with its devotion to 'cost' effectiveness and its ivory tower approach to medicine, will always discredit itself.
In practice there is only one choice: I too believe in cost-effective medicine – the one that under our new dog's-dinner (evidence-based we are assured) contract pays the bills.
Dr Neil Tallant